{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T03:29:42Z","timestamp":1648956582269},"reference-count":15,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.3892\/ol.2014.1976","type":"journal-article","created":{"date-parts":[[2014,3,14]],"date-time":"2014-03-14T13:27:25Z","timestamp":1394803645000},"page":"2130-2134","source":"Crossref","is-referenced-by-count":3,"title":["Usefulness of short-term eltrombopag treatment as a supportive treatment in hepatocellular carcinoma patients with cirrhosis and severe thrombocytopenia: A report of two cases"],"prefix":"10.3892","volume":"7","author":[{"given":"TAKUMI","family":"KAWAGUCHI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MASAHITO","family":"NAKANO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MANABU","family":"SATANI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHUJI","family":"SUMIE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHINGO","family":"YAMADA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KEISUKE","family":"AMANO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RYOKO","family":"KUROMATSU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MICHIO","family":"SATA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2014,3,14]]},"reference":[{"key":"key20180108102501_b1-ol-07-06-2130","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jhep.2008.03.009","article-title":"Thrombocytopenia associated with chronic liver disease","volume":"48","author":"Afdhal","year":"2008","journal-title":"J Hepatol"},{"key":"key20180108102501_b2-ol-07-06-2130","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2739\/kurumemedj.56.9","article-title":"Thrombocytopenia, an important interfering factor of antiviral therapy and hepatocellular carcinoma treatment for chronic liver diseases","volume":"56","author":"Kawaguchi","year":"2009","journal-title":"Kurume Med J"},{"key":"key20180108102501_b3-ol-07-06-2130","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1056\/NEJMoa073275","article-title":"Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura","volume":"357","author":"Bussel","year":"2007","journal-title":"N Engl J Med"},{"key":"key20180108102501_b4-ol-07-06-2130","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1056\/NEJMoa1110709","article-title":"Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia","volume":"367","author":"Afdhal","year":"2012","journal-title":"N Engl J Med"},{"key":"key20180108102501_b5-ol-07-06-2130","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1007\/s00535-012-0600-5","article-title":"Efficacy and safety of eltrombopag in Japanese patients with chronic liver disease and thrombocytopenia: a randomized, open-label, phase II study","volume":"47","author":"Kawaguchi","year":"2012","journal-title":"J Gastroenterol"},{"key":"key20180108102501_b6-ol-07-06-2130","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1056\/NEJMoa073255","article-title":"Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C","volume":"357","author":"McHutchison","year":"2007","journal-title":"N Engl J Med"},{"key":"key20180108102501_b7-ol-07-06-2130","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/MEG.0b013e3282f246e6","article-title":"Thrombopoietin is a growth factor for rat hepatic progenitors","volume":"20","author":"Schmelzer","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"key20180108102501_b8-ol-07-06-2130","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1182\/blood.V91.3.923","article-title":"Thrombopoietin and its receptor, c-mpl, are constitutively expressed by mouse liver endothelial cells: evidence of thrombopoietin as a growth factor for liver endothelial cells","volume":"91","author":"Cardier","year":"1998","journal-title":"Blood"},{"key":"key20180108102501_b9-ol-07-06-2130","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.21231","article-title":"Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity","volume":"44","author":"Lisman","year":"2006","journal-title":"Hepatology"},{"key":"key20180108102501_b10-ol-07-06-2130","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1111\/j.1478-3231.2011.02617.x","article-title":"NADPH oxidase-mediated platelet isoprostane over-production in cirrhotic patients: implication for platelet activation","volume":"31","author":"Basili","year":"2011","journal-title":"Liver Int"},{"key":"key20180108102501_b11-ol-07-06-2130","first-page":"2056","article-title":"Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia","volume":"367","author":"Violi","year":"2012","journal-title":"N Engl J Med"},{"key":"key20180108102501_b12-ol-07-06-2130","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1160\/TH12-07-0522","article-title":"Function of eltrombopag-induced platelets compared to platelets from control patients with immune thrombocytopenia","volume":"109","author":"Haselboeck","year":"2013","journal-title":"Thromb Haemost"},{"key":"key20180108102501_b13-ol-07-06-2130","first-page":"3509","article-title":"Thrombopoietin receptor expression in human cancer cell lines and primary tissues","volume":"55","author":"Columbyova","year":"1995","journal-title":"Cancer Res"},{"key":"key20180108102501_b14-ol-07-06-2130","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/hepr.12006","article-title":"Effects of thrombopoietin on growth of hepatocellular carcinoma: Is thrombopoietin therapy for liver disease safe or not?","volume":"43","author":"Nozaki","year":"2012","journal-title":"Hepatol Res"},{"key":"key20180108102501_b15-ol-07-06-2130","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1471-2407-13-121","article-title":"Results of a phase I dose escalation study of eltrombopag in patients with advanced soft tissue sarcoma receiving doxorubicin and ifosfamide","volume":"13","author":"Chawla","year":"2013","journal-title":"BMC Cancer"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2014.1976\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,16]],"date-time":"2020-08-16T09:17:26Z","timestamp":1597569446000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2014.1976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,14]]},"references-count":15,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,3,14]]},"published-print":{"date-parts":[[2014,6]]}},"alternative-id":["10.3892\/ol.2014.1976"],"URL":"https:\/\/doi.org\/10.3892\/ol.2014.1976","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,14]]}}}